News & Updates
Showing Urology articles
Showing
Show Multimedia Only

SRT plus GnRH agonist with acetate/prednisone, apalutamide improves prostate cancer survival
24 Feb 2023
byStephen Padilla
Postoperative salvage radiotherapy (SRT) plus 6 months of androgen deprivation therapy (ADT) with abiraterone acetate/prednisone (AAP) and apalutamide (Apa) results in better progression-free (PFS) and metastasis-free survival (MFS) among patients with prostate cancer, findings from FORMULA-509 have shown. However, the primary analysis did not reach the prespecified threshold for statistical significance.
24 Feb 2023

Chronic pelvic pain in men tied to severe sexual dysfunction
02 Feb 2023
Men with urologic chronic pelvic pain syndrome (UCPPS) tend to suffer a more severe sexual dysfunction, including erectile (ED) and ejaculatory dysfunction, when compared to their healthy counterparts or patients with other chronic pain conditions, reveals a study.
02 Feb 2023







